Skip to content
Research Article Open access CC BY 4.0

Decoding Tumor Drug Resistance: Present Status and Future Landscapes

Jonathan Nyebuchi

Asian Oncology Research Journal · pp. 62–70 · Published 30 Dec 2024

10.9734/aorj/2024/v7i194

Abstract

Tumor drug resistance remains a significant challenge in cancer therapy, leading to treatment failure and disease progression. Understanding the mechanisms underlying drug resistance is crucial for developing effective strategies to overcome it. This review discusses the recent advances in the mechanisms of tumor drug resistance, including genetic and epigenetic alterations, the role of the tumor microenvironment, and cancer stem cells. It also explores the latest approaches to circumvent drug resistance, such as targeted therapies, combination treatments, nanotechnology-based drug delivery systems, immunotherapies, and epigenetic therapies. The review highlights the clinical implications of these advances and outlines future directions for research to improve patient outcomes.

Tumor drug resistance cancer therapy genetic mutations epigenetics tumor microenvironment cancer stem cells targeted therapy immunotherapy nanotechnology combination therapy

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.